Literature DB >> 8170877

The effect of different nitrate preparations on plasma heparin concentrations and the activated partial thromboplastin time.

M J Brack1, R S More, P J Hubner, A H Gershlick.   

Abstract

There is evidence that intravenous nitrates which are frequently used in acute coronary syndromes may interfere with the anticoagulant effect of heparin. We compared the effect of two different nitrate preparations on the activated partial thromboplastin time (APTT), anti-thrombin III activity (AT III) and plasma heparin levels in patients (n = 50) undergoing routine percutaneous transluminal coronary angioplasty (PTCA) for stable angina. Patients were randomized to either: (1) intravenous heparin and nitroglycerin (GTN); or (2) intravenous heparin and isosorbide dinitrate. The APTT, plasma heparin concentration and AT III activity were measured before PTCA and at 2 and 4 hours after commencement of infusions. Both groups received identical doses of heparin. Group 1 patients received a constant dose of 16.6 micrograms/minute of GTN, and group 2 patients received 33.3 micrograms/minute of isosorbide dinitrate. At 4 hours the median APTT ratio was significantly lower in group 1 compared with group 2 (2.6 versus 4.5) (P < 0.05) as was the plasma heparin concentration (0.18 U/ml versus 0.32 U/ml (P < 0.05). However, no significant difference in APTT ratios or plasma heparin concentrations were noted at any of the other sample times. AT III activity was not significantly different between the groups at any sample time. Within-group analysis showed significantly lower APTT ratio and heparin concentrations at 4 hours compared with the respective 2 hour values. These results would suggest that there is a potential impairment of anticoagulation with low-dose intravenous nitroglycerin and to a lesser extent with low-dose isosorbide dinitrate. Early and frequent monitoring may therefore be appropriate when intravenous nitrates and heparin are used in combination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170877      PMCID: PMC2397649          DOI: 10.1136/pgmj.70.820.100

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  Absence of drug interaction between heparin and nitroglycerin. Randomized placebo-controlled crossover study.

Authors:  V Bode; D Welzel; G Franz; U Polensky
Journal:  Arch Intern Med       Date:  1990-10

2.  Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormality.

Authors:  R C Becker; J M Corrao; E G Bovill; J M Gore; S P Baker; M L Miller; F V Lucas; J A Alpert
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

3.  Propylene glycol-induced heparin resistance during nitroglycerin infusion.

Authors:  J Col; C Col-Debeys; E Lavenne-Pardonge; P Meert; L Hericks; M C Broze; M Moriau
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

4.  Heparin resistance induced by intravenous nitroglycerin. A word of caution when both drugs are used concomitantly.

Authors:  M A Habbab; J I Haft
Journal:  Arch Intern Med       Date:  1987-05

5.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.

Authors:  E Falk
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

6.  Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitro.

Authors:  M J Brack; R S More; E Spring; A H Gershlick
Journal:  Thromb Res       Date:  1993-05-15       Impact factor: 3.944

7.  The effect of low dose nitroglycerin on plasma heparin concentrations and activated partial thromboplastin times.

Authors:  M J Brack; R S More; P J Hubner; A H Gershlick
Journal:  Blood Coagul Fibrinolysis       Date:  1993-02       Impact factor: 1.276

8.  Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy.

Authors:  K Kaplan; R Davison; M Parker; J Przybylek; J R Teagarden; M Lesch
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

9.  Does nitroglycerin induce heparin resistance?

Authors:  N E Lepor; D K Amin; L Berberian; P K Shah
Journal:  Clin Cardiol       Date:  1989-08       Impact factor: 2.882

10.  Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.

Authors:  S G Ellis; G S Roubin; J Wilentz; J S Douglas; S B King
Journal:  Am Heart J       Date:  1989-04       Impact factor: 4.749

View more
  1 in total

1.  Clinical pharmacokinetics of molsidomine.

Authors:  B Rosenkranz; B R Winkelmann; M J Parnham
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.